Equity-Based Investments |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Equity-Based Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
| Equity-based investments |
As of December 31, 2025, the Company’s investment in Norman Berry amounted to $828,440. As of December 31, 2024, the Company’s investment in Norman Berry and Cumberland amounted to $617,607 and $3,025,000, respectively. The financial position of the Company’s equity-based investments are summarized below as of December 31, 2025 and 2024:
|
||||||||||||||||||||||||||||||||||||||||||||||||